Answer
Grazax increases grass pollen-specific IgG4 antibodies over three years of treatment, with the increase still present two years after treatment completion, although the clinical significance has not been established.
Sources for this answer
- GRAZAX 75,000 SQ-T sublingual lyophilisateALK-Abello Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 17Document updated
Sources checked